You-ri Kang

Gwangju, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Application of the 2024 and 2017 McDonald criteria at disease onset in a multicenter Korean MS cohort.

Application of the 2024 and 2017 McDonald criteria at disease onset in a multicenter Korean MS cohort.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 25, 2026

Facial Neuropathy in Patients with Recurrent Painful Ophthalmoplegic Neuropathy.

Facial Neuropathy in Patients with Recurrent Painful Ophthalmoplegic Neuropathy.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: June 18, 2026

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Journal: Neurology

Published: May 15, 2026

Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.

Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.

Journal: Neurology

Published: March 12, 2026

Outcomes and disease activity during and after pregnancy in Asian women with MOGAD.

Outcomes and disease activity during and after pregnancy in Asian women with MOGAD.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 26, 2026

Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA network open

Published: February 13, 2026

Rarity of silent progression: PIRA and RAW in myelin oligodendrocyte glycoprotein antibody-associated disease.

Rarity of silent progression: PIRA and RAW in myelin oligodendrocyte glycoprotein antibody-associated disease.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 13, 2026

Optimizing kappa free light chain index thresholds for multiple sclerosis (MS) diagnosis in low-MS prevalence regions: Insights from an Asian cohort.

Optimizing kappa free light chain index thresholds for multiple sclerosis (MS) diagnosis in low-MS prevalence regions: Insights from an Asian cohort.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 27, 2025

Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.

Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 23, 2025

MOG-IgG Positivity Does Not Equal MOGAD: Diagnostic Pitfall and Misapplication of the International MOGAD Panel Proposed Criteria in Real-World Practice.

MOG-IgG Positivity Does Not Equal MOGAD: Diagnostic Pitfall and Misapplication of the International MOGAD Panel Proposed Criteria in Real-World Practice.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: September 18, 2025

MOG-IgG Frequency in Multiple Sclerosis: Diagnostic Challenges With Low-Titer Results.

MOG-IgG Frequency in Multiple Sclerosis: Diagnostic Challenges With Low-Titer Results.

Journal: European journal of neurology

Published: June 01, 2025

Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease.

Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 29, 2025

Showing 1-12 of 29

Last Updated: 09/26/2026